Immunomedics
Immunomedics is a biopharmaceutical company that specializes in the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other serious diseases. The company's advanced proprietary technologies allow it to create humanized antibodies that can be used either alone in unlabeled or "naked" form, or conjugated with radioisotopes, chemotherapeutics, or toxins, to create highly targeted agents.
History[edit | edit source]
Immunomedics was founded in 1982 by David M. Goldenberg, a pioneer in the field of radioimmunotherapy. The company's initial focus was on the development of monoclonal antibody-based imaging agents, but it soon expanded its research and development efforts to include therapeutic applications of its technologies.
Products and Pipeline[edit | edit source]
Immunomedics' product portfolio includes a number of monoclonal antibodies that are in various stages of clinical development. The company's lead product, Sacituzumab Govitecan, is a first-in-class antibody-drug conjugate that has shown promise in the treatment of several types of solid tumors.
In addition to Sacituzumab Govitecan, Immunomedics has several other products in its pipeline, including Labetuzumab Govitecan, a second antibody-drug conjugate that is currently in Phase II clinical trials for the treatment of colorectal cancer.
Research and Development[edit | edit source]
Immunomedics' research and development efforts are focused on the discovery and development of novel monoclonal antibodies and antibody-drug conjugates for the treatment of cancer and other serious diseases. The company's proprietary technologies, including its Dock-and-Lock (DNL) platform, allow it to create highly specific and potent therapeutic agents.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
